Abbonarsi

Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response - 18/06/22

Doi : 10.1016/j.biopha.2022.113270 
Virginia Actis Dato a, b, 1, Aleyda Benitez-Amaro c, d, 1, Eduardo Garcia c, d, 1, Lene Claudi c, d, Maria Teresa LaChica Lhoëst c, d, Antoni Iborra e, Joan Carles Escola-Gil f, Jose Maria Guerra g, h, Valerie Samouillan i, Carlos Enrich j, k, Gustavo Chiabrando a, b, , 2 , Vicenta Llorente-Cortés c, d, h, , 3
a Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina 
b Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Córdoba, Argentina 
c Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Barcelona, Spain 
d Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain 
e SCAC, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain 
f Metabolic Basis of Cardiovascular Risk, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau. CIBER de Diabetes y enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona. Spain 
g Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Universitat Autonoma de Barcelona, Barcelona, Spain 
h CIBERCV, Institute of Health Carlos III, 28029 Madrid, Spain 
i CIRIMAT, Université de Toulouse, Université Paul Sabatier, Equipe PHYPOL, 31062 Toulouse, France 
j Unitat de Biologia Cel·lular, Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain 
k Centre de Recerca Biomèdica CELLEX, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain 

Correspondence to: Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Haya de la Torre s/n, Ciudad Universitaria, 5000 Córdoba, Argentina. Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba Haya de la Torre s/n, Ciudad Universitaria Córdoba 5000 Argentina ⁎⁎ Correspondence to: Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí 77-79, 08041 Barcelona, Spain. Institute of Biomedical Research of Barcelona (IIBB)-Spanish National Research Council (CSIC), Biomedical Research Institute Sant Pau (IIB Sant Pau) Sant Quintí 77-79 Barcelona 08041 Spain

Abstract

Background

Antibodies against the P3 sequence (Gly1127-Cys1140) of LRP1 (anti-P3 Abs) specifically block cholesteryl ester (CE) accumulation in vascular cells. LRP1 is a key regulator of insulin receptor (InsR) trafficking in different cell types. The link between CE accumulation and the insulin response are largely unknown. Here, the effects of P3 peptide immunization on the alterations induced by a high-fat diet (HFD) in cardiac insulin response were evaluated.

Methods

Irrelevant (IrP)- or P3 peptide-immunized rabbits were randomized into groups fed either HFD or normal chow. Cardiac lipid content was characterized by thin-layer chromatography, confocal microscopy, and electron microscopy. LRP1, InsR and glucose transporter type 4 (GLUT4) levels were determined in membranes and total lysates from rabbit heart. The interaction between InsR and LRP1 was analyzed by immunoprecipitation and confocal microscopy. Insulin signaling activity and glucose uptake were evaluated in HL-1 cells exposed to rabbit serum from the different groups.

Findings

HFD reduces cardiac InsR and GLUT4 membrane levels and the interactions between LRP1/InsR. Targeting the P3 sequence on LRP1 through anti-P3 Abs specifically reduces CE accumulation in the heart independently of changes in the circulating lipid profile. This restores InsR and GLUT4 levels in cardiac membranes as well as the LRP1/InsR interactions of HFD-fed rabbits. In addition, anti-P3 Abs restores the insulin signaling cascade and glucose uptake in HL-1 cells exposed to hypercholesterolemic rabbit serum.

Interpretation

LRP1-immunotargeting can block CE accumulation within the heart with specificity, selectivity, and efficacy, thereby improving the cardiac insulin response; this has important therapeutic implications for a wide range of cardiac diseases.

Funding

Fundació MARATÓ TV3 : grant 101521-10 , Instiuto de Salud Carlos III (ISCIII) and ERDF PI18/01584 , Fundación BBVA Ayudas a Equipos de Investigación 2019. SECyT-UNC grants PROYECTOS CONSOLIDAR 2018-2021; FONCyT, Préstamo BID PICT grant 2015-0807 and grant 2017-4497 .

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




ga1

Il testo completo di questo articolo è disponibile in PDF.

Highlights

LRP1 plays a crucial role in cholesteryl ester (CE) accumulation in cardiomyocytes.
LRP1 immunotargeting blocks myocardial CE accumulation independently of blood and hepatic lipids.
Targeting cardiomyocyte CE accumulation improves cardiac insulin response.
P3 immunization changes the ultrastructure of lipid droplets in the heart.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : High-fat diet, Lipid droplets, Cholesteryl esters, Heart, Lipoprotein, Insulin, LRP1


Mappa


© 2022  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 152

Articolo 113270- agosto 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Peucedanum praeruptorum Dunn polysaccharides regulate macrophage inflammatory response through TLR2/TLR4-mediated MAPK and NF-κB pathways
  • Ming Zhao, Jing Hou, Sichun Zheng, Xiaodan Ma, Xinyu Fu, Songhua Hu, Kai Zhao, Wei Xu
| Articolo seguente Articolo seguente
  • Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK/Nrf2/GPx4 axis
  • Ya Zhang, Qifang Wu, Jian Liu, Zhongshan Zhang, Xiaojing Ma, Yaoyue Zhang, Jiawen Zhu, Ronald W. Thring, Mingjiang Wu, Yitian Gao, Haibin Tong

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.